Skip to content
A close up of a logo.
  • Use Cases
    • Clinical Trials
    • Laboratories
    • Diagnostic Testing Devices
    • Toxicology Testing
  • Platform
  • Customers
  • About
  • News
  • Contact Us
  • Use Cases
    • Clinical Trials
    • Laboratories
    • Diagnostic Testing Devices
    • Toxicology Testing
  • Platform
  • Customers
  • About
  • News
  • Contact Us
Get Started

Blog

  1. Home>
  2. Rymedi News>
  3. David Stefanich appointed to Advisory Board at High Point University Phillips School of Business 
You are currently viewing David Stefanich appointed to Advisory Board at High Point University Phillips School of Business 

David Stefanich appointed to Advisory Board at High Point University Phillips School of Business 

  • Post author:Kristina
  • Post category:Rymedi News

Rymedi is proud to announce that CEO David Stefanich has been appointed to the Advisory Board at High Point University Phillips School of Business . His healthcare expertise will be useful in their launch of a new Healthcare Management Major as well as support for the MBA in Healthcare Management program.

You Might Also Like

Read more about the article Rymedi named to 2025 Best Tech Start-up in South Carolina list

Rymedi named to 2025 Best Tech Start-up in South Carolina list

April 9, 2025
Read more about the article Transforming Toxicology Testing: Rymedi’s Blockchain Solution for Paperless Documentation

Transforming Toxicology Testing: Rymedi’s Blockchain Solution for Paperless Documentation

September 26, 2024

One Stop Testing Shop: ATC Healthcare Services and Rymedi Offer Nation’s First Integrated COVID-19 Testing Solution

July 30, 2020

Recent Posts

  • Rymedi named to 2025 Best Tech Start-up in South Carolina list
  • Rymedi and Public Good Pharma / Crowd Funded Cures Announce Strategic Partnership to Improve Access to Medicine by leveraging Web3.0-backed Financial Innovation
  • My One Medical Source® (MOMS) and Rymedi Partner
  • Rymedi Reaches Major Milestone with First Patent Grant
  • Transforming Toxicology Testing: Rymedi’s Blockchain Solution for Paperless Documentation
X-twitter Linkedin Instagram
A white text on a black background.
  • Use Cases
    • Clinical Trials
    • Laboratories
    • Diagnostic Testing Devices
    • Toxicology Testing
  • Platform
  • Customers
  • About
  • News
  • Contact Us
  • Use Cases
    • Clinical Trials
    • Laboratories
    • Diagnostic Testing Devices
    • Toxicology Testing
  • Platform
  • Customers
  • About
  • News
  • Contact Us
Get Started

Copyright © 2025 Rymedi, Inc. All Rights Reserved.

Terms of Use  |  Privacy Policy